Innovative Medical's 2026 interim report shows net loss of 52.83 million yuan, widening year-on-year

Jiemian··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Innovative Medical released its 2026 interim report, with net profit attributable to the parent company at negative 52.83 million yuan, a loss expansion of 41.47 million yuan compared with the same period last year. The company's total operating revenue was 338 million yuan, down 15.88% year-on-year, and net cash flow from operating activities was negative 2.49 million yuan, down 102.97% year-on-year. The latest gross margin was 1.44%, down 10.62 percentage points from the same period last year, and diluted earnings per share was negative 0.12 yuan.

Impact on assets 1

Others▼ · 1 stocks
© 2026 MarketIVNews